Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer

SIMPLE SUMMARY: Prostate cancer is the second leading cause of cancer deaths in men. Attempts to improve patient outcomes include trials of neoadjuvant androgen deprivation therapy for patients with high-risk disease. Neoadjuvant treatment refers to androgen deprivation therapy that is administered...

Descripción completa

Detalles Bibliográficos
Autores principales: Pechlivanis, Maree, Campbell, Bethany K., Hovens, Christopher M., Corcoran, Niall M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750084/
https://www.ncbi.nlm.nih.gov/pubmed/35008330
http://dx.doi.org/10.3390/cancers14010166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750084/
https://www.ncbi.nlm.nih.gov/pubmed/35008330
http://dx.doi.org/10.3390/cancers14010166

Ejemplares similares